| 764188 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
183 Therapeutic T cells exhibit distinct vulnerability to glucose deprivation in tumors which can be overcome with an engineered glucose transporter |
2021-11-01 |
10.1136/jitc-2021-sitc2021.183 |
Jana Jessica, Wang Yiyang, Menk Ashley, Frisch Andrew, Delgoffe Greg |
| 764187 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
180 T cell phenotype drives restructuring of tumor microenvironment to balance T cell longevity and tumor control: insights from multiplexed imaging and multi-scale agent based modeling |
2021-11-01 |
10.1136/jitc-2021-sitc2021.180 |
Hickey John, Nolan Garry, Covert Markus, Agmon Eran, Horowitz Nina, Sunwoo John |
| 764186 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
178 Expansion of Tumor-Infiltrating Lymphocytes and Marrow-Infiltrating Lymphocytes from Pediatric Malignant Solid Tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.178 |
Metts Jonathan, Hensel Jonathan, Alfaro Alejandro, Olmo Brook, Pilon-Thomas Shari, Mullinax John, Leon Ivanna |
| 764185 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.177 |
Hawkins Robert, Jiang Yizhou, Lorigan Paul C, Thistlethwaite Fiona C, Pillai Manon, Thomas Martine, Kirillova Natalia, Bridgeman John S, Kueberuwa Gray, Guest Ryan D, Roberts Zachary J |
| 764184 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
173 Expression of a membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence of MSLN-targeted TRuC-T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.173 |
Fleury Michelle, McCarthy Derrick, Horton Holly, Anderson Courtney, Watt Amy, Zieba Adam, Webb Lindsay, Ding Jian, Tighe Robert, Hofmeister Robert, Gutierrez Dario |
| 764183 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
164 Potent tumor organoid infiltration and killing by PBMC-derived effector cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.164 |
Borriello Frank, Keegan Joshua, Lederer James |
| 764182 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
163 Improved anti-tumor activity of next-generation TCR-engineered T cells through CD8 co-expression |
2021-11-01 |
10.1136/jitc-2021-sitc2021.163 |
Bajwa Gagan, Gunesch Justin, Azoulay-Alfaguter Inbar, Mata Melinda, Mohamed Ali, Kalra Mamta, Walter Steffen |
| 764181 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
149 In vitro efficacy studies to support engineered T cell therapies |
2021-11-01 |
10.1136/jitc-2021-sitc2021.149 |
Munnik Sabrina de, Hazenoot Monique, Vermond Sophie, McLaughlin Rene, Guadagnoli Marco, Moiset Gemma, Holt Sann, Vlaming Marijn |
| 764180 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
942 The tumor microbiome correlates with response to immune checkpoint inhibitors in renal cell carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.942 |
Wheeler Caroline, Yang Yuanquan, Spakowicz Daniel, Hoyd Rebecca, Li Mingjia |
| 764179 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
941 Stromal cell sialylation suppresses T cells in inflammatory tumour microenvironments: a new tumour stromal cell immune checkpoint? |
2021-11-01 |
10.1136/jitc-2021-sitc2021.941 |
Treacy Oliver, Egan Hannah, Lynch Kevin, Leonard Niamh, Veirman Kim De, Vanderkerken Karin, Egan Laurence, Ritter Thomas, Hogan Aisling, Redmond Keara, Krawczyk Janusz, Hynes Sean, Kerr Emma, Dunne Philip, O’Dwyer Michael, Ryan Aideen |
